Profile data is unavailable for this security.
About the company
China Shineway Pharmaceutical Group Ltd is an investment holding company primarily engaged in research and development, manufacturing and trading of Chinese pharmaceutical products. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The Company operates its business in mainland China and Hong Kong markets.
- Revenue in HKD (TTM)3.78bn
- Net income in HKD936.99m
- Incorporated2002
- Employees2.87k
- LocationChina Shineway Pharmaceutical Group LtdLuanchengSHIJIAZHUANG ChinaCHN
- Websitehttp://www.shineway.com.hk
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shandong Boan Biotechnology Co Ltd | 856.16m | 36.24m | 4.73bn | 714.00 | 119.56 | 1.90 | 35.89 | 5.52 | 0.0636 | 0.0636 | 1.51 | 4.00 | 0.2530 | 1.34 | 1.73 | 1,053,085.00 | 1.07 | -- | 1.41 | -- | 71.70 | -- | 4.23 | -- | 1.45 | 1.81 | 0.2827 | -- | 17.50 | -- | 161.31 | -- | -- | -- |
| VIVA Biotech Holdings | 2.08bn | 194.91m | 4.90bn | 2.09k | 32.48 | 1.10 | 9.75 | 2.36 | 0.0708 | 0.0708 | 0.6808 | 2.09 | 0.2612 | 4.24 | 4.94 | 1,007,213.00 | 3.22 | -1.28 | 3.81 | -1.56 | 37.44 | 34.30 | 12.33 | -4.94 | 1.44 | -- | 0.2283 | -- | -7.84 | 43.80 | 244.08 | -8.85 | 27.82 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -153.71m | 5.17bn | 197.00 | -- | 6.24 | -- | -- | -0.7658 | -0.7658 | 0.00 | 4.17 | 0.00 | -- | -- | 0.00 | -12.48 | -- | -13.69 | -- | -- | -- | -- | -- | 4.68 | -- | 0.2296 | -- | -- | -- | 32.53 | -- | -- | -- |
| Tong Ren Tang Technologies Co Ltd | 7.86bn | 488.40m | 5.66bn | 3.89k | 11.59 | 0.6858 | 4.58 | 0.7202 | 0.3813 | 0.3813 | 6.14 | 6.44 | 0.482 | 0.8615 | 6.00 | 1,969,535.00 | 5.47 | 7.44 | 8.57 | 12.07 | 39.82 | 42.21 | 11.34 | 15.10 | 2.79 | -- | 0.1913 | 39.34 | 7.18 | 10.15 | -11.59 | 4.55 | -8.30 | 3.37 |
| Ocumension Therapeutics | 615.11m | -281.98m | 5.71bn | 505.00 | -- | 1.38 | -- | 9.28 | -0.3764 | -0.3764 | 0.8214 | 5.08 | 0.1571 | 4.30 | 3.35 | 1,257,900.00 | -7.20 | -24.03 | -7.62 | -25.71 | 42.58 | 58.38 | -45.84 | -400.90 | 4.86 | -- | 0.0223 | -- | 69.38 | 365.95 | 29.36 | -- | 213.01 | -- |
| Beijing Tong Ren Tang Chinese Medicine | 1.71bn | 515.36m | 7.53bn | 789.00 | 14.62 | 1.87 | 12.00 | 4.41 | 0.6157 | 0.6157 | 2.04 | 4.81 | 0.3878 | 0.4134 | 4.92 | 2,185,246.00 | 12.14 | 15.34 | 13.34 | 17.17 | 63.00 | 68.94 | 31.29 | 39.16 | 11.43 | -- | 0.0327 | 52.52 | 5.69 | 2.38 | -7.42 | -2.09 | 20.50 | 8.76 |
| China Shineway Pharmaceutical Group Ltd | 3.78bn | 936.99m | 8.10bn | 2.87k | 7.89 | 0.9164 | 10.39 | 2.14 | 1.24 | 1.24 | 5.01 | 10.68 | 0.3299 | 1.15 | 3.81 | 1,174,894.00 | 8.17 | 8.29 | 10.75 | 10.38 | 73.36 | 74.83 | 24.77 | 18.67 | 3.39 | -- | 0.0419 | 37.49 | -16.35 | 6.90 | -13.35 | 10.80 | 8.92 | 19.39 |
| CStone Pharmaceuticals | 229.08m | -426.61m | 8.72bn | 93.00 | -- | 22.63 | -- | 38.08 | -0.3273 | -0.3273 | 0.1768 | 0.2612 | 0.1487 | 1.38 | 1.68 | 1,696,892.00 | -27.69 | -39.13 | -54.45 | -60.19 | -12.18 | 66.69 | -186.23 | -170.86 | 1.20 | -29.83 | 0.554 | -- | -12.21 | -- | 75.16 | -- | -- | -- |
| SSY Group Ltd | 4.58bn | 658.92m | 8.76bn | 5.70k | 13.54 | 1.23 | 7.79 | 1.91 | 0.223 | 0.223 | 1.55 | 2.46 | 0.3616 | 2.27 | 2.11 | 751,065.60 | 5.27 | 9.41 | 6.34 | 12.43 | 42.68 | 56.47 | 14.58 | 17.65 | 2.40 | 14.91 | 0.346 | 42.91 | -10.67 | 4.49 | -19.53 | -1.36 | -8.36 | 9.73 |
| Hbm Holdings Ltd | 904.32m | 571.07m | 10.28bn | 210.00 | 15.96 | 4.25 | 17.19 | 11.37 | 0.7405 | 0.7405 | 1.14 | 2.78 | 0.3856 | 6.32 | 32.64 | 5,796,901.00 | 24.77 | -42.87 | 30.77 | -53.24 | 92.95 | 96.12 | 64.25 | -292.58 | 6.02 | 28.63 | 0.1857 | -- | -57.43 | 47.71 | -87.81 | -- | -55.31 | -- |
| China Traditional Chinese Med Hldg CoLtd | 17.63bn | -299.61m | 10.32bn | 15.58k | -- | 0.4408 | 11.36 | 0.5854 | -0.0595 | -0.0595 | 3.50 | 4.65 | 0.4326 | 1.59 | 1.71 | 1,052,615.00 | -0.93 | 3.48 | -1.42 | 5.24 | 47.66 | 54.69 | -2.15 | 7.39 | 1.51 | 9.55 | 0.1333 | 21.27 | -8.90 | 2.89 | -95.79 | -49.14 | -15.28 | -48.82 |
| Luye Pharma Group Ltd | 6.98bn | 449.06m | 10.79bn | 5.12k | 22.62 | 0.611 | 6.74 | 1.55 | 0.1194 | 0.1194 | 1.86 | 4.42 | 0.2083 | 2.42 | 2.37 | 1,354,931.00 | 1.91 | 1.98 | 3.26 | 3.16 | 66.85 | 68.37 | 9.15 | 8.04 | 1.24 | 2.35 | 0.4227 | 0.00 | -1.33 | -0.9503 | -11.40 | -19.50 | -10.95 | -- |
| Fujian Haixi Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 10.92bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 47.39 | -- | 15.86 | -- | -- | -- |
Data as of Feb 16 2026. Currency figures normalised to China Shineway Pharmaceutical Group Ltd's reporting currency: Hong Kong Dollar HKD
4.80%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 11.00m | 1.33% |
| Lancelot Asset Management ABas of 31 Dec 2024 | 7.50m | 0.91% |
| Dimensional Fund Advisors LPas of 30 Nov 2025 | 6.49m | 0.79% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 6.40m | 0.77% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 2.80m | 0.34% |
| First Trust Advisors LPas of 06 Feb 2026 | 1.51m | 0.18% |
| Allianz Global Investors GmbHas of 31 Oct 2025 | 1.26m | 0.15% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 1.13m | 0.14% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 864.00k | 0.10% |
| E Fund Asset Management Co. Ltd.as of 30 Jun 2025 | 711.00k | 0.09% |
More ▼
Data from 31 Dec 2024 - 31 Dec 2025Source: FactSet Research Systems Inc.
